Evidence map›Paper›PMID 41174933›Full record

ArticleInternational journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics2026

Adverse perinatal outcomes associated with macrosomia in nulliparous women: A multicenter cohort study.

Tzuria Peled, Omer Ben Yishai, Eliel Shapira, Maayan Bas Lando, Hen Y Sela, Sorina Grisaru-Granovsky, Misgav Rottenstreich

Abstract readMulticenter Study
In one paragraph

Article in International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tzuria PeledDepartment of Obstetrics and Gynecology, Faculty of Medicine, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.ORCID https://orcid.org/0009-0005-5377-7782
Omer Ben YishaiFaculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
Eliel ShapiraDepartment of Obstetrics and Gynecology, Faculty of Medicine, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Maayan Bas LandoDepartment of Obstetrics and Gynecology, Faculty of Medicine, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Hen Y SelaDepartment of Obstetrics and Gynecology, Faculty of Medicine, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Sorina Grisaru-GranovskyDepartment of Obstetrics and Gynecology, Faculty of Medicine, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.
Misgav RottenstreichDepartment of Obstetrics and Gynecology, Faculty of Medicine, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveOur study aimed to evaluate the combined risk of macrosomia and nulliparity. We investigated whether macrosomia is independently associated with an increased rate of intrapartum cesarean delivery (CD) and adverse maternal and neonatal outcomes among nulliparous women delivering at term.

methodsWe conducted a retrospective cohort study including nulliparous women with singleton, term (37-42 weeks) deliveries between 2005 and 2024 at two university-affiliated medical centers in Jerusalem, Israel. Women who delivered macrosomic neonates (birth weight ≥4000 g) were compared with those delivering neonates weighing 3000-3500 g. Exclusions included multifetal gestations, preterm deliveries, elective cesareans, fetal anomalies, and antepartum demise. The primary outcome was intrapartum cesarean delivery. Secondary outcomes included a range of maternal and neonatal complications. Multivariable logistic regression was used to adjust for potential confounders including maternal obesity, pre-gestational diabetes, labor induction, and gestational age at delivery.

resultsAmong 86 801 eligible nulliparous women, 2762 (3.2%) delivered macrosomic neonates and 40 963 (47.2%) served as the control group. The rate of intrapartum CD was significantly higher among macrosomic deliveries compared to controls (18.6% vs. 7.8%, P < 0.01), though this association was not statistically significant after adjustment (adjusted odds ratio [aOR] 1.81, 95% confidence interval [CI]: 0.91-3.58). Macrosomia was independently associated with increased odds of shoulder dystocia (aOR 33.42, 95% CI: 11.32-98.68), postpartum hemorrhage (aOR 2.13, 95% CI: 1.79-2.54), blood transfusion (aOR 2.45, 95% CI: 1.51-3.98), chorioamnionitis (aOR 2.03, 95% CI: 1.57-2.61), neonatal intensive care unit admission (aOR 1.62, 95% CI: 1.15-2.29), neonatal hypoglycemia (aOR 2.23, 95% CI: 1.32-3.77), and Erb's palsy or clavicular fracture (aOR 9.43, 95% CI: 4.01-22.21). Stratification by birth weight categories revealed a dose-response relationship, with the highest complication rates among neonates >4500 g.

conclusionIn nulliparous women delivering at term, macrosomia is independently associated with a higher risk of multiple adverse maternal and neonatal outcomes. These findings underscore the compounded risk faced by nulliparous women with macrosomic fetuses and highlight the need for enhanced prenatal surveillance and individualized delivery planning in this population.

Indexed as

Cesarean SectionFetal MacrosomiaPregnancy OutcomeAdultCohort StudiesFemaleGestational AgeHumansInfant, NewbornIsraelLogistic ModelsParityPregnancyRetrospective StudiesRisk Factorsbirth weightcesarean deliverymacrosomiamaternal outcomesneonatal outcomesnulliparity

Identifiers

PMID41174933
PMCPMC12988399

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.